Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_assertion type Assertion NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_head.
- NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_provenance.
- NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_assertion evidence source_evidence_literature NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_provenance.
- NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_assertion SIO_000772 18044827 NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_provenance.
- NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_assertion wasDerivedFrom befree-20150227 NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_provenance.
- NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_assertion wasGeneratedBy ECO_0000203 NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_provenance.